Inari VISION Registry

Last updated: May 12, 2025
Sponsor: Inari Medical
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pulmonary Embolism

Chest Pain

Venous Thromboembolism

Treatment

Inari Medical Commercially Available Devices

Clinical Study ID

NCT06600542
24-003
  • Ages > 18
  • All Genders

Study Summary

This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Willing and able to provide informed consent per institution and geographicalrequirements

  2. Has received treatment with an eligible Inari Medical device. NOTE: If patients areconsented prior to their procedure and the procedure does not take place, thepatient will be considered a screen failure.

  3. Currently within enrollment window relative to their procedure

  4. Age ≥ 18 years

Exclusion

Exclusion Criteria:

  1. Is or will be inaccessible for registry follow-up

  2. Meets exclusion criteria required by local requirements

  3. Current or planned participation in another drug or device study that, in theinvestigator's opinion, would interfere with participation in this registry

  4. Is pregnant or breastfeeding at the time of enrollment

Study Design

Total Participants: 500
Treatment Group(s): 1
Primary Treatment: Inari Medical Commercially Available Devices
Phase:
Study Start date:
March 07, 2025
Estimated Completion Date:
December 31, 2029

Connect with a study center

  • Queen Elizabeth University Hospital

    Glasgow,
    United Kingdom

    Active - Recruiting

  • Royal Free Hospital

    London,
    United Kingdom

    Active - Recruiting

  • UCLH University College London Hospital

    London,
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.